Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats

Microvascular Research

Volumn 83, Issue 2, 2012, Pages 205-212

  Zhang, Bo ^a,b   Luo, Ying ^a   Liu, Man Ling ^a   Wang, Jing ^a   Xu, Dun Quan ^a   Dong, Ming Qing ^a   Liu, Yi ^a   Xu, Min ^a   Dong, Hai Ying ^a   Zhao, Peng Tao ^a   Gao, Yu Qi ^c   Li, Zhi Chao ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHELERYTHRINE; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHENYLEPHRINE; PROTEIN KINASE C; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HYPOXIC LUNG VASOCONSTRICTION; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

RATTUS;

EID: 84856773010     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2011.09.014     Document Type: Article

References (28)

1. Al-Abed Y., Dabideen D., Aljabari B., et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J. Biol. Chem. 2005, 280:36541-36544.
2. Burger-Kentischer A., Goebel H., Seiler R., et al. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 2002, 105:1561-1566.
3. Calandra T., Echtenacher B., Roy D.L., et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 2000, 6:164-170.
4. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
5. De Salvatore G., De Salvia M.A., Piepoli A.L., et al. Effects of in vivo treatment with interleukins 1beta and 6 on rat mesenteric vascular bed reactivity. Auton. Autacoid Pharmacol. 2003, 23:125-131.
6. Donnelly S.C., Haslett C., Reid P.T., et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 1997, 3:320-323.
7. Frid M.G., Brunetti J.A., Burke D.L., et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am. J. Pathol. 2006, 168:659-669.
8. Gao L., Flores C., Fan-Ma S., et al. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Transl. Res. 2007, 150:18-29.
9. Goirand F., Bardou M., Guerard P., et al. ETA, mixed ETA/ETB receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channels. J. Cardiovasc. Pharmacol. 2003, 41:117-125.
10. Harnett K.M., Biancani P. Calcium-dependent and calcium-independent contractions in smooth muscles. Am. J. Med. 2003, 115:24S-30S.
11. Leach R.M., Robertson T.P., Twort C.H., et al. Hypoxic vasoconstriction in rat pulmonary and mesenteric arteries. Am. J. Physiol. 1994, 266:L223-L231.
12. Liu S.F., Dewar A., Crawley D.E., et al. Effect of tumor necrosis factor on hypoxic pulmonary vasoconstriction. J. Appl. Physiol. 1992, 72:1044-1049.
13. Madjdpour C., Jewell U.R., Kneller S., et al. Decreased alveolar oxygen induces lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L360-L367.
14. Minamino T., Christou H., Hsieh C.M., et al. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:8798-8803.
15. Mitchell R.A., Metz C.N., Peng T., et al. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 1999, 274:18100-18106.
16. Morand E.F. New therapeutic target in inflammatory disease:macrophage migration inhibitory factor. Intern. Med. J. 2005, 35:419-426.
17. Onodera S., Nishihiram J., Koyama Y., et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Arthritis Rheum. 2004, 50:1437-1447.
18. Pakozdi A., Amin M.A., Haas C.S., et al. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res. Ther. 2006, 8:R132.
19. Perros F., Dorfmüller P., Souza R., et al. Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur. Respir. J. 2007, 29:937-943.
20. Savale L., Tu L., Rideau D., et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir. Res. 2009, 10:6.
21. Stenmark K.R., Davie N.J., Reeves J.T., et al. Hypoxia, leukocytes, and the pulmonary circulation. J. Appl. Physiol. 2005, 98:715-721.
22. Stenmark K.R., Fagan K.A., Frid M.G. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res. 2006, 99:675-691.
23. Stojanović I., Cvjetićanin T., Lazaroski S., et al. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology 2009, 126:74-83.
24. Tsai B.M., Wang M., Pitcher J.M., et al. Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L1215-L1219.
25. 2+ influx and release in normal and hypoxic pulmonary hypertension rats. Eur. J. Pharmacol. 2010, 640:129-138.
26. Ward J.P., McMurtry I.F. Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr. Opin. Pharmacol. 2009, 9:287-296.
27. Weissmann N., Voswinckel R., Hardebusch T., et al. Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. Am. J. Physiol. Lung Cell. Mol. Physiol. 1999, 276:L90-L95.
28. Xu D.Q., Luo Y., Liu Y., et al. Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats. Respir. Res. 2010, 11:182.